HFactor (HWTR) 10-Q 18 Feb 21 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Feb. 15, 2020
Document And Entity Information [Abstract]
Entity Registrant Name	FICAAR, INC
Entity Central Index Key	0001144546
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity File Number	000-1144546
Entity Ex Transition Period	false
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	DE
Entity Common Stock, Shares Outstanding		44,093,276

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash
Total Assets
Current Liabilities
Accounts payable and accrued expenses	27,701	24,401
Accrued Interest	24,199	22,076
Advances payable -officer	2,668	2,469
Total Current Liabilities	54,568	48,946
Long-Term Liabilities
Note payable - Third party	100,695	100,695
Note payable - Related party	6,525	6,525
Total Long-Term Liabilities	107,220	107,220
Total Liabilities	161,788	156,166
Commitments and Contingencies
Stockholders' Deficit
Preferred stock 10,000,000, $.001 par value shares authorized, no shares issued and outstanding
Common stock 200,000,000, $.001 par value shares authorized; 44,093,276 shares issued and outstanding at March 31, 2020 and December 31,2019	44,093	44,093
Additional paid-in capital	(44,093)	(44,093)
Accumulated deficit	(161,788)	(156,166)
Total Stockholders' Deficit	(161,788)	(156,166)
Total Liabilities and Stockholders' Deficit

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized	200,000,000	200,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	44,093,276	44,093,276
Common stock, shares outstanding	44,093,276	44,093,276

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenues
Professional fees:
Audit fees	1,500	2,000
Other operating expenses	2,114	4,300
Total expenses	3,614	6,300
Loss from operations	(3,614)	(6,300)
Interest expense	(2,008)	(1,490)
Net Loss	$ (5,622)	$ (7,790)
Net Loss per common shares outstanding-Basic and diluted:
Net Loss per share attributable to common stockholders	$ (0.0001)	$ (0.0002)
Weighted average shares outstanding	44,093,276	44,093,276

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Preferred Stock	Common stock	Additional Paid-In Capital	Deficit Accumulated During Development Stage	Total
Balance at Dec. 31, 2018		$ 44,093	$ (44,093)	$ (117,398)	$ (117,398)
Balance, shares at Dec. 31, 2018		44,093,276
Net loss				(7,790)	(7,790)
Balance at Mar. 31, 2019		$ 44,093	(44,093)	(125,188)	(125,188)
Balance, shares at Mar. 31, 2019		44,093,276
Balance at Dec. 31, 2019		$ 44,093	(44,093)	(156,166)	(156,166)
Balance, shares at Dec. 31, 2019		44,093,276
Net loss				(5,622)	(5,622)
Balance at Mar. 31, 2020		$ 44,093	$ (44,093)	$ (161,788)	$ (161,788)
Balance, shares at Mar. 31, 2020		44,093,276

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
OPERATING ACTIVITIES:
Net loss	$ (5,622)	$ (7,790)
Adjustments for changes in working capital:
Accounts payable and accrued expenses	3,300	6,300
Accrued interest	2,123	1,490
Advances payable-officer	199
Net cash (used ) in operating activities
FINANCING ACTIVITIES:
Proceeds from borrowing
Cash flows from financing activities
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents - Beginning
Cash and cash equivalents - Ending
Supplemental disclosures:
Cash paid for interest
Cash paid for income taxes

Description of Business

Description of Business	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	NOTE 1 - DESCRIPTION OF BUSINESS History Ficaar, Inc. (the "Company" or "Ficaar") was incorporated in July 2001 under the name OwnerTel, Inc. The name of the Company was changed to Ficaar, Inc. in December of 2007. The Company operates its business through its wholly owned subsidiary, Standard Canna, Inc. ("Standard"), a Florida corporation formed in 2014, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation formed in 2014; and Standard Property Group Inc., a California corporation formed in 2014; and Precious Holdings, Inc. which was formed in April of 2011 in the state of Delaware and is wholly owned by the Company. In August 2012, certain shareholders of the Ficaar (the "Shareholders"), representing a majority of the issued and outstanding common stock of Ficaar, entered into an agreement and consummated such agreement with Sneaker Charmz, Inc., a Delaware corporation, whereby 72,020,000 shares of common stock of Ficaar was assigned by the Shareholders to Sneaker Charmz. Thereafter, Sneaker Charmz, Ficaar and David Cicalese consummated a transaction where the shares of common stock of Ficaar owned by Sneaker Charmz were transferred and assigned to Mr. Cicalese and Mr. Cicalese transferred his ownership of Sneaker Charmz to Ficaar. Thus, Sneaker Charmz became a wholly owned subsidiary of Ficaar and Mr. Cicalese then owning 85% of the total issued and outstanding common stock of Ficaar. In addition, the Company divested Medical Cannabis Network, Inc., a company incorporated pursuant to the laws of Delaware and Ficaar's former wholly-owned subsidiary. Mr. Jason Draizin resigned as an officer and member of Ficaar's board of directors and Mr. David Cicalese (President and sole member of the Board of Directors of Sneaker Charmz) was appointed as President and a member of the Board of Directors of Ficaar. Following the consummation of the Agreement, Ficaar is engaged in the business of Sneaker Charmz, the development, marketing and sales of designer charms for footwear. In January 2014, Mr. David Cicalese, President, a member of the Board of Directors and majority shareholder of Ficaar, contributed 100 shares of Precious Holdings, Inc., a Delaware corporation, which consists of all of the issued and outstanding equity of Precious Holdings, Inc. Thus, Precious Holdings Inc. became a wholly owned subsidiary of the Company. On November 16, 2014, we acquired 100% of the outstanding common stock of Standard Canna, Inc. ("Standard"), a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation; and Standard Property Group Inc., a California corporation, in exchange for 110,000 shares of our common stock pursuant to a Transfer Agreement (the "Agreement"), by and among, the Company and Jonas Zetzel, sole shareholder of Standard. In June 2015, the Board of Directors and shareholders representing a majority of the issued and outstanding common stock of the Company appointed Dawn Cames as President of the Company and a member of its Board of Directors In connection with the reverse acquisition and recapitalization, all share and per share amounts have been retroactively restated. Since the transaction is considered a reverse acquisition and recapitalization, accounting guidance does not apply for purposes of presenting pro-forma financial information. Present Operations The business of the Company, operating through its wholly owned subsidiary, Standard, is the purchase, development and operation of growing space and related facilities and leasing our facilities to marijuana growers and dispensary owners for their operations in jurisdictions where such operations are consistent with state and local law.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation and Basis of Presentation The accompanying (a) condensed consolidated balance sheet at December 31, 2019, has been derived from audited financial statements and (b) condensed consolidated unaudited financial statements as of March 31, 2020 and 2019, have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and related footnotes included in our Annual Report on Form 10K for the year ended December 31, 2019 (the "2019 Annual Report"), filed with the Securities and Exchange Commission (the "SEC") on February 2, 2021. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statement presentation. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2020, are not necessarily indicative of the results of operations expected for the year ending December 31, 2020. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States ("GAAP") and are expressed in United States dollars. These consolidated financial statements include the accounts of Ficaar and its wholly owned subsidiaries, all of which are inactive, Standard Canna, Inc., a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation; and Standard Property Group Inc., a California corporation; and as well as Precious Holdings, Inc., a Delaware corporation. All inter-company balances and transactions have been eliminated on consolidation. Development Stage The Company is in the development stage as defined in Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic 915, "Development Stage Entities." The fiscal year end is December 31. The Company is a start-up venture with little or no operating history and has no revenues. In its development stages and infancy, the officers of the Company spent considerable time and effort in research and development in order to create a niche in the cannabis industry. Going Concern The financial statements have been prepared on a going concern basis, and do not reflect any adjustments related to the uncertainty surrounding the Company's development stage losses. The Company currently has no revenues and has incurred losses during its development stage. As of March 31, 2020, the Company has yet to commence substantial operations. In the course of its start-up activities, the Company has sustained operating losses and expects to incur operating losses in 2020. These principal factors raise substantial doubt concerning the Company's ability to continue as a going concern. Management has financed the Company's operations principally through loans from its President who is also a principal shareholder. It is the Company's intent to continue to raise funds in this manner and to raise funds through the sale of equity securities until the Company attains profitability. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Revenue Recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, services have been rendered, the sales price is fixed or determinable, and collectibility is reasonably assured. To date the Company has not generated any revenue. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates. Research and Development Expense Costs related to research and development, which primarily consists of consulting for logo and packaging design, are charged to expense as incurred. The Company has not incurred any research and development for the three months ended March 31, 2020 and 2019. Net Loss Per Share The Company computes net income (loss) per share in accordance with ASC Topic 260, Earning per Share, formerly Statement of Accounting Standards SFAS No. 128, "Earnings per Share", which requires presentation of both basic and diluted earnings per share ("EPS") on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) before and after discontinued operations, by the weighted average number of common shares outstanding (denominator) during the period, including contingently issuable shares where the contingency has been resolved. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Income Taxes The Company accounts for income taxes under ASC 740 (formerly FASB 109) "Accounting for Income Taxes". Under ASC 740 deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates in recognized in income in the period which includes the enactment date. In June, 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48 (FIN 48), "Accounting for Uncertainty in Income Taxes" - An interpretation of FASB Statement No. 109 and codified under ASC 740. FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an entity's financial statements in accordance with Statement of Financial Accounting Standards No. 109, "Accounting for Income Taxes". This interpretation prescribed a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax provision taken or expected to be taken in a tax return. In addition, FIN 48 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition. Based on its evaluation, the Company has concluded that there are no significant uncertain tax positions regarding recognition in financial statements. The Company's evaluation was performed for the tax years, ended December 31, 2019, 2018, 2017, 2016 and 2015 for US federal income tax and state income taxes, the years which remain subject to examination by major tax jurisdictions as of December 31, 2019. Recent Accounting Pronouncements We have considered all other recently issued accounting pronouncements during 2019 and 2018 and do not believe the adoption of such pronouncements will have a material impact on our consolidated financial statements.

Notes Payable -Third Party

Notes Payable -Third Party	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
NOTES PAYABLE -THIRD PARTY	NOTE 3 - NOTES PAYABLE -THIRD PARTY The Company has issued a note with a principal balance due in the amount of $100,698 as at March 31, 2020 and December 31, 2019, respectively. With interest payable at 8% per annum and due June 30, 2022. The note is convertible to common stock at the lesser of: (i) a 50% discount to market price for the Company's stock; and (ii) $0.01 per share. As of March 31, 2020, and December 31,2019 the Company has determined that there is no beneficial conversion feature since the stock has no quoted market value or other means to determine market.

Notes Payable - Related Party

Notes Payable - Related Party	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
NOTES PAYABLE - RELATED PARTY	NOTE 4 - NOTES PAYABLE - RELATED PARTY The Company has issued a note payable to its' majority shareholder and President with a principal balance due in the amount of $6,525 as at March 31, 2020 and December 31,2019 with interest payable at 7.0% per annum maturing June 30, 2022.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5 - COMMITMENTS AND CONTINGENCIES Legal –

Equity

Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
EQUITY	NOTE 6 - EQUITY Common stock The Company has authorized 200,000,000 shares of $.001 par value common stock. As of March 31, 2020, and December 31, 2019, the Company had 44,093,276 shares, respectively, of common stock issued and outstanding. Preferred Stock The Company has authorized 10,000,000 shares of $.001 par value preferred stock. The Company has no preferred stock issued and outstanding.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 7 - INCOME TAXES The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes. During the current period, the Company incurred a net loss and therefore has no tax liability.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 8 - RELATED PARTY TRANSACTIONS Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial and operating decisions. Details of transactions between the Company and related parties are disclosed below: The following have been identified as related parties: David Cicalese Director and greater 10% shareholder Dawn Cames President Concorde Consulting Holder of convertible note of $100,695 as of March 31,2020 and December 31, 2019 The following balances existed with related parties: March 31, December 31, 2020 2019 Balance sheet: Note Payable-Concorde $ 100,695 $ 100,695 Note Payable-D. Cicalese $ 6,525 $ 6,525 Advances Payable -officer $ 2,668 $ 2,469 Accrued Interest $ 109,888 $ 109,689 Income Statement Interest expense $ 2,008 $ 1,490

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The accompanying (a) condensed consolidated balance sheet at December 31, 2019, has been derived from audited financial statements and (b) condensed consolidated unaudited financial statements as of March 31, 2020 and 2019, have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and related footnotes included in our Annual Report on Form 10K for the year ended December 31, 2019 (the "2019 Annual Report"), filed with the Securities and Exchange Commission (the "SEC") on February 2, 2021. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statement presentation. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2020, are not necessarily indicative of the results of operations expected for the year ending December 31, 2020. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States ("GAAP") and are expressed in United States dollars. These consolidated financial statements include the accounts of Ficaar and its wholly owned subsidiaries, all of which are inactive, Standard Canna, Inc., a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation; and Standard Property Group Inc., a California corporation; and as well as Precious Holdings, Inc., a Delaware corporation. All inter-company balances and transactions have been eliminated on consolidation.
Development Stage	Development Stage The Company is in the development stage as defined in Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic 915, "Development Stage Entities." The fiscal year end is December 31. The Company is a start-up venture with little or no operating history and has no revenues. In its development stages and infancy, the officers of the Company spent considerable time and effort in research and development in order to create a niche in the cannabis industry.
Going Concern	Going Concern The financial statements have been prepared on a going concern basis, and do not reflect any adjustments related to the uncertainty surrounding the Company's development stage losses. The Company currently has no revenues and has incurred losses during its development stage. As of March 31, 2020, the Company has yet to commence substantial operations. In the course of its start-up activities, the Company has sustained operating losses and expects to incur operating losses in 2020. These principal factors raise substantial doubt concerning the Company's ability to continue as a going concern. Management has financed the Company's operations principally through loans from its President who is also a principal shareholder. It is the Company's intent to continue to raise funds in this manner and to raise funds through the sale of equity securities until the Company attains profitability. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Revenue Recognition	Revenue Recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, services have been rendered, the sales price is fixed or determinable, and collectibility is reasonably assured. To date the Company has not generated any revenue.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
Research and Development Expense	Research and Development Expense Costs related to research and development, which primarily consists of consulting for logo and packaging design, are charged to expense as incurred. The Company has not incurred any research and development for the three months ended March 31, 2020 and 2019.
Net Loss Per Share	Net Loss Per Share The Company computes net income (loss) per share in accordance with ASC Topic 260, Earning per Share, formerly Statement of Accounting Standards SFAS No. 128, "Earnings per Share", which requires presentation of both basic and diluted earnings per share ("EPS") on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) before and after discontinued operations, by the weighted average number of common shares outstanding (denominator) during the period, including contingently issuable shares where the contingency has been resolved. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740 (formerly FASB 109) "Accounting for Income Taxes". Under ASC 740 deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates in recognized in income in the period which includes the enactment date. In June, 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48 (FIN 48), "Accounting for Uncertainty in Income Taxes" - An interpretation of FASB Statement No. 109 and codified under ASC 740. FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an entity's financial statements in accordance with Statement of Financial Accounting Standards No. 109, "Accounting for Income Taxes". This interpretation prescribed a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax provision taken or expected to be taken in a tax return. In addition, FIN 48 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition. Based on its evaluation, the Company has concluded that there are no significant uncertain tax positions regarding recognition in financial statements. The Company's evaluation was performed for the tax years, ended December 31, 2019, 2018, 2017, 2016 and 2015 for US federal income tax and state income taxes, the years which remain subject to examination by major tax jurisdictions as of December 31, 2019.
Recent Accounting Pronouncements	Recent Accounting Pronouncements We have considered all other recently issued accounting pronouncements during 2019 and 2018 and do not believe the adoption of such pronouncements will have a material impact on our consolidated financial statements.

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Schedule of balances existed with related parties	March 31, December 31, 2020 2019 Balance sheet: Note Payable-Concorde $ 100,695 $ 100,695 Note Payable-D. Cicalese $ 6,525 $ 6,525 Advances Payable -officer $ 2,668 $ 2,469 Accrued Interest $ 109,888 $ 109,689 Income Statement Interest expense $ 2,008 $ 1,490

Description of Business (Detail

Description of Business (Details) - shares	1 Months Ended
	Nov. 16, 2014	Jan. 31, 2014	Aug. 31, 2012
Number of shares assigned by sharesholders of entity			72,020,000
Percentage of issued and outstanding of common stock held by majority shareholders			85.00%
Standard Cann Inc [Member]
Business acquisition, percentage of voting interests acquired	100.00%
Business acquisition, equity interest issued or issuable, number of shares	110,000
Precious Holdings Inc [Member]
Number of shares held by entity through contribution from majority shareholders		100

Notes Payable -Third Party (Det

Notes Payable -Third Party (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Notes payable third parties	$ 100,695	$ 100,695
Notes Payable - Third Parties [Member]
Notes payable interest rate	8.00%	8.00%
Notes payable, maturity date	Jun. 30, 2022
Convertible debt, Description	The note is convertible to common stock at the lesser of: (i) a 50% discount to market price for the Company’s stock; and (ii) $0.01 per share.

Notes Payable - Related Party (

Notes Payable - Related Party (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Principal balance due amount	$ 6,525	$ 6,525
Notes Payable - Related Parties [Member]
Percentage of interest payable	7.00%	7.00%
Maturity date	Jun. 30, 2022

Equity (Details)

Equity (Details) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Common stock, shares authorized	200,000,000	200,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	44,093,276	44,093,276
Common stock, shares outstanding	44,093,276	44,093,276
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Balance sheet:
Accrued Interest	$ 109,888	$ 109,689
Interest expense	2,008	1,490
Advances Payable -officer [Member]
Balance sheet:
Accrued Interest	2,668	2,469
Note Payable-Concorde [Member]
Balance sheet:
Accrued Interest	100,695	100,695
Note Payable-D. Cicalese [Member]
Balance sheet:
Accrued Interest	$ 6,525	$ 6,525

Related Party Transactions (D_2

Related Party Transactions (Details Textual) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
David Cicalese [Member]
Related Party Transactions (Textual)
Minimum percentage of share to be held by related party	10.00%
Notes Payable Third Parties [Member] | Concorde Consulting [Member]
Related Party Transactions (Textual)
Debt instrument face amount	$ 100,695	$ 100,695